DISCONTINUED OPERATIONS - ADDITIONAL INFORMATION (DETAILS) (USD $) Share data in Millions	1 Months Ended	12 Months Ended
Oct. 31, 2010	Jun. 30, 2010	Jun. 30, 2009
Divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott), net of assumed and transferred liabilities	$ 2,800,000,000
Shares tendered for Folgers coffee subsidiary (in shares)			38.7
Increase of treasury stock as a result of the merger, shares of common stock of the Company were tendered by shareholders and exchanged for all shares of Folgers common stock			2,466,000,000
After-tax gain on the transaction, which is included in net earnings from discontinued operations		$ 1,464,000,000	$ 2,011,000,000

Gain (loss) after tax expense (benefit), not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph b

Name:	us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
Namespace Prefix:	us-gaap
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration